Physician profile

Eldere Germain

Internal Medicine · Orlando, FL

NPI 1467019109

$5,479.19

in general payments reported to CMS, 2019-2025

32 companies · $1,643 in 2025

The $1,643 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,154.04
Education$19.62

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $1,018.94 2021-2025 Farxiga, Airsupra, Breztri
Glaxosmithkline, LLC. $746.32 2021-2025 Arexvy, Shingrix, Trelegy Ellipta
Amgen INC. $513.05 2022-2025 Repatha, Otezla, Repatha
Novo Nordisk INC $497.42 2020-2025 Wegovy, Ozempic, Rybelsus
Bayer Healthcare Pharmaceuticals INC. $421.79 2022-2025
Pfizer INC. $402.53 2020-2025
Abbvie INC. $302.49 2021-2024
Boehringer Ingelheim Pharmaceuticals, INC. $221.10 2022-2025 Jardiance
Actelion Pharmaceuticals US, INC. $171.03 2025 Uptravi, Opsumit, Opsynvi
Avadel Cns Pharmaceuticals, LLC $155.90 2025 Lumryz
C2n Diagnostics, LLC $130.66 2025 Precivityad2
Lilly USA, LLC $123.62 2022-2025 Mounjaro, Zepbound, Jardiance
Astellas Pharma US INC $120.00 2023 Veozah
Grifols USA, LLC $72.07 2024 Prolastin-C Liquid
Otsuka America Pharmaceutical, INC. $70.46 2023 Rexulti, Jynarque
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $62.89 2023-2024
Viatris Specialty LLC $47.64 2025 Yupelri
Redhill Biopharma INC. $38.35 2020
Sanofi-Aventis U.S. LLC $37.02 2022
Averitas Pharma INC. $33.97 2023-2024 Qutenza
Shield Therapeutics INC $32.01 2024-2025
Dexcom, INC. $31.91 2022-2024 Dexcom G6 Transmitter
Merck Sharp & Dohme LLC $31.81 2020-2022
Idorsia Pharmaceuticals US INC $30.29 2023 Quviviq
Exact Sciences Corporation $28.34 2024 Cologuard Collection Kit
Phathom Pharmaceuticals, INC. $24.09 2024-2025 Voquezna
Boston Scientific Corporation $23.54 2025 General - Pain Management
Vifor Pharma, INC. $23.46 2023 Veltassa
Watermark Medical, INC. $19.67 2024
Corcept Therapeutics $18.21 2025 Korlym
Teva Pharmaceuticals USA, INC. $15.30 2021
Mylan Specialty L.P. $13.31 2024 Yupelri

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eldere Germain

$5,479.19

in general payments reported 2019-2025

Years
2020-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $1,643 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/6448208/eldere-germain

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.